High-Quality Clinical Trial Reveals Cannabis Extract Effectively Reduces Chronic Lower Back Pain

A high-quality clinical trial demonstrates that a targeted cannabis extract can significantly reduce chronic lower back pain, offering a new hope for pain sufferers and advancing medical cannabis research.
A recent phase 3 clinical trial has provided robust evidence that a specially formulated cannabis extract can significantly alleviate chronic lower back pain. This groundbreaking study, published in the journal Nature Medicine, involved over 800 participants suffering from persistent lower back pain unrelieved by conventional non-opioid medications. Participants took daily doses of the cannabis-derived compound, called VER-01, or a placebo over a 12-week period. The results demonstrated a notable average pain reduction of 1.9 points on a 10-point scale in the extract group, compared to just 0.6 in the placebo group. Furthermore, at the six-month mark, those on the cannabis extract experienced a total pain decrease of nearly 2.9 points, along with improvements in sleep quality, physical functioning, and overall quality of life. Each dose of VER-01 contains 2.5 milligrams of THC, the primary psychoactive component of cannabis. Importantly, the study reported no serious side effects or signs of addiction, with common minor effects including dizziness, dry mouth, sleepiness, and nausea—all of which diminished over time. The lead researcher, Professor Matthias Karst from Hannover Medical School, emphasized that no feelings of being "high" were observed during the trial, highlighting the extract’s safety profile. Elsewhere, experts praised the study as the best evidence yet showing that specific cannabis compounds can help in managing chronic pain, although cautions remain about the general use of cannabis products outside regulated medical formulations. Researchers also highlighted that the proprietary nature of VER-01 distinguishes it from recreational cannabis or over-the-counter CBD products, which often vary widely in potency and purity. Pain specialists warned that this study does not imply all cannabis or CBD products will be effective, underlining the importance of specifically developed and regulated medicinal formulations for pain relief. Overall, this research marks a significant step toward incorporating cannabis-based treatments into mainstream pain management strategies, offering hope for those suffering from debilitating lower back pain.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Insurers Contend with Rising Costs of GLP-1 Medications and Consider Patient Deprescription Strategies
Rising costs of GLP-1 medications lead insurers to restrict coverage and explore deprescription strategies, impacting patient care and weight management efforts.
Dietary Supplement Nicotinamide Shows Promise in Skin Cancer Prevention
Recent research suggests that nicotinamide, a form of vitamin B3, can significantly reduce the risk of skin cancer, especially in high-risk individuals, offering a promising preventive strategy.
Genetic Factors Influence Why Some People Age Faster Than Others
New research identifies over 400 genes linked to different types of accelerated aging, paving the way for personalized anti-aging therapies and improved health in older adults.



